Smruthi Organics (BSE 540686)₹161.55−0.58%Pharmaceuticals
In the Jun 2026 quarter (standalone), Smruthi Organics reported sales of ₹29.34 Cr, up 55.5% from Jun 2025, and net profit of ₹2.87 Cr. For the year to Mar 2026, sales were ₹102 Cr and net profit ₹2.99 Cr.
Company filings, standalone accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 29.64 | 23.52 | 39.72 | 27.30 | 29.42 | 31.28 | 38.13 | 18.87 | 31.64 | 22.31 | 29.07 | 29.34 |
| Expenses | 25.24 | 24.74 | 35.70 | 26.91 | 26.58 | 27.18 | 33.53 | 18.63 | 26.70 | 18.35 | 25.23 | 23.57 |
| Operating Profit | 4.42 | −1.17 | 4.07 | 0.44 | 2.88 | 4.16 | 4.67 | 0.28 | 5.00 | 3.99 | 3.89 | 5.80 |
| OPM % | 14.9% | −5.0% | 10.3% | 1.7% | 9.8% | 13.4% | 12.3% | 1.5% | 15.8% | 17.9% | 13.4% | 19.8% |
| Other Income | 0.00 | 0.00 | 0.07 | 0.00 | 0.02 | 0.00 | 0.09 | 0.05 | 0.02 | −0.45 | −0.08 | −0.05 |
| Interest | 0.40 | 0.33 | 0.38 | 0.42 | 0.45 | 0.52 | 0.53 | 0.47 | 0.67 | 0.26 | 0.32 | 0.32 |
| Depreciation | 1.37 | 1.44 | 1.58 | 1.28 | 1.32 | 1.36 | 1.49 | 1.40 | 1.50 | 1.66 | 1.74 | 1.59 |
| Profit before tax | 2.65 | −2.94 | 2.17 | −1.24 | 1.12 | 2.28 | 2.73 | −1.53 | 2.84 | 1.63 | 1.76 | 3.85 |
| Tax % | 22.6% | −22.0% | 30.8% | −26.4% | 31.9% | 35.4% | 18.6% | −28.5% | 27.8% | 14.7% | 39.6% | 25.7% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | 2.06 | −2.28 | 1.51 | −0.91 | 0.77 | 1.47 | 2.22 | −1.09 | 2.05 | 1.39 | 1.06 | 2.87 |
| EPS (Rs) | 1.80 | −1.99 | 1.32 | −0.79 | 0.67 | 1.28 | 1.94 | −0.95 | 1.79 | 1.21 | 0.92 | 2.51 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 74.13 | 79.05 | 97.17 | 137 | 131 | 126 | 133 | 141 | 128 | 126 | 102 | 112 |
| Expenses | 63.24 | 69.26 | 94.28 | 121 | 116 | 98.39 | 115 | 131 | 116 | 114 | 89.29 | 93.85 |
| Operating Profit | 10.99 | 9.99 | 2.99 | 16.99 | 14.99 | 28.95 | 17.97 | 9.99 | 11.99 | 11.99 | 12.98 | 18.68 |
| OPM % | 14.0% | 13.0% | 3.4% | 12.0% | 12.0% | 23.0% | 14.0% | 7.0% | 9.0% | 10.0% | 13.0% | 16.6% |
| Other Income | 0.00 | 1.01 | 0.00 | 1.01 | 4.01 | 1.01 | 1.01 | 0.00 | 0.00 | 0.00 | 0.00 | −0.56 |
| Interest | 5.01 | 4.01 | 4.01 | 4.01 | 3.01 | 1.01 | 1.01 | 1.01 | 1.01 | 2.01 | 2.01 | 1.57 |
| Depreciation | 3.99 | 3.99 | 3.99 | 3.98 | 3.99 | 3.98 | 3.99 | 4.98 | 5.97 | 5.98 | 5.98 | 6.49 |
| Profit before tax | 1.99 | 2.99 | −4.99 | 9.98 | 11.97 | 23.95 | 13.97 | 3.99 | 4.99 | 4.98 | 4.98 | 10.08 |
| Tax % | 55.0% | 39.1% | −31.0% | 30.0% | 30.0% | 29.0% | 25.0% | 8.0% | 28.1% | 27.0% | 27.0% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −0.33 | 0.00 |
| Net Profit | 0.99 | 1.99 | −2.99 | 6.98 | 7.96 | 16.94 | 9.96 | 3.98 | 3.98 | 3.98 | 2.99 | 7.37 |
| EPS (Rs) | 0.62 | 1.38 | −2.81 | 6.00 | 7.38 | 14.90 | 9.04 | 3.60 | 3.13 | 3.10 | 2.99 | 6.43 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 11.1% | 14.1% | 20.1% | 33.1% | 55.1% | 48.1% | 48.1% | 50.1% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.98 | 3.98 | 3.99 | 3.99 | 3.99 | 3.99 | 10.96 | 10.96 | 10.95 | 10.96 | 10.96 | 10.96 |
| Reserves | 26.01 | 27.03 | 27.98 | 24.98 | 33.01 | 38.93 | 48.92 | 55.94 | 56.90 | 57.96 | 59.95 | 61.87 |
| Borrowings | 44.92 | 36.94 | 32.91 | 30.94 | 27.96 | 15.95 | 9.98 | 2.99 | 5.98 | 11.98 | 16.96 | 7.98 |
| Other Liabilities | 33.84 | 34.84 | 19.91 | 24.88 | 36.86 | 29.86 | 20.89 | 17.92 | 31.85 | 36.81 | 22.89 | 21.89 |
| Total Liabilities | 109 | 103 | 84.79 | 84.79 | 101 | 87.73 | 91.75 | 87.81 | 106 | 118 | 112 | 104 |
| Fixed Assets | 34.86 | 31.90 | 29.91 | 29.89 | 29.90 | 31.88 | 30.89 | 32.90 | 36.85 | 39.85 | 44.87 | 46.84 |
| CWIP | 1.01 | 0.99 | 0.99 | 0.99 | 2.01 | 0.00 | 0.99 | 1.01 | 2.01 | 0.99 | 2.99 | 2.99 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 71.88 | 68.90 | 53.89 | 53.91 | 68.91 | 55.85 | 59.87 | 52.90 | 65.82 | 76.87 | 63.90 | 53.87 |
| Inventories | 17.81 | 19.33 | 19.40 | 21.03 | 22.65 | 17.07 | 18.10 | 19.91 | 23.94 | 29.73 | 28.28 | 28.31 |
| Trade receivables | 21.71 | 19.32 | 21.13 | 25.33 | 36.45 | 24.61 | 21.40 | 28.55 | 37.01 | 41.08 | 32.52 | 19.33 |
| Cash & equivalents | 1.68 | 1.62 | 1.56 | 1.72 | 4.15 | 3.56 | 16.11 | 0.56 | 1.74 | 0.56 | 0.50 | 2.26 |
| Total Assets | 109 | 103 | 84.79 | 84.79 | 101 | 87.73 | 91.75 | 87.81 | 106 | 118 | 112 | 104 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 8.98 | 13.98 | 8.99 | 4.99 | 11.97 | 20.96 | 22.95 | 1.99 | 11.99 | 3.99 | 9.98 | 21.97 |
| Cash from investing activity | −0.99 | 0.00 | 0.00 | −2.99 | −3.99 | −4.99 | −2.99 | 6.98 | −9.96 | −6.98 | −10.96 | −8.97 |
| Cash from financing activity | −8.03 | −14.05 | −9.02 | −2.01 | −5.01 | −17.05 | −7.02 | −12.04 | −2.01 | 3.01 | 1.01 | −12.04 |
| Net cash flow | −1.01 | 0.00 | 0.00 | 0.00 | 2.01 | −1.01 | 13.06 | −3.01 | 0.00 | 0.00 | 0.00 | 1.01 |
| Capex | 1.24 | 1.37 | 1.71 | 4.02 | 4.95 | 4.77 | 3.95 | 6.54 | 9.45 | 8.23 | 11.51 | 8.46 |
| Free cash flow | 7.01 | 13.01 | 8.01 | 1.01 | 6.99 | 17.01 | 19.02 | −4.01 | 3.01 | −4.01 | −2.01 | 14.02 |
| CFO / OP % | 184.0% | 128.0% | 93.0% | 159.0% | 71.0% | 160.0% | 101.0% | 33.0% | 136.0% | 46.0% | 100.0% | 182.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 103 | 95 | 97 | 95 | 97 | 68 | 62 | 78 | 96 | 117 | 94 | 69 |
| Inventory days | 123 | 166 | 145 | 126 | 92 | 75 | 100 | 91 | 96 | 150 | 151 | 228 |
| Days payable | 106 | 128 | 123 | 130 | 120 | 97 | 81 | 50 | 98 | 144 | 85 | 111 |
| Cash conversion cycle | 121 | 134 | 120 | 93 | 69 | 47 | 81 | 119 | 94 | 124 | 161 | 187 |
| Working capital days | 2 | 8 | 1 | 7 | 78 | 32 | 52 | 99 | 73 | 94 | 92 | 85 |
| ROCE % | 0.0% | 9.0% | 10.0% | −1.0% | 21.0% | 25.0% | 39.0% | 21.0% | 7.0% | 8.0% | 8.0% | 8.0% |
For the Jun 2026 quarter, Smruthi Organics reported sales of ₹29.34 Cr, up 55.5% year on year and net profit of ₹2.87 Cr. The operating margin was 19.8%.
Smruthi Organics' sales for the year to Mar 2026 were ₹102 Cr; over the last twelve months they were ₹112 Cr.
Net profit for the year to Mar 2026 was ₹2.99 Cr, and ₹7.37 Cr over the last twelve months. Earnings per share over the same trailing period were ₹6.43.
Smruthi Organics reported borrowings of ₹7.98 Cr at Mar 2026, against cash and equivalents of ₹2.26 Cr.
Cash from operations was ₹21.97 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹14.02 Cr.